Ottawa, Ontario – The Minister of Science, Kirsty Duncan, yesterday launched a $2 million initiative designed to accelerate the translation of research results into practical applications in healthcare for the benefit of Canadians.
Genome Canada’s 2012 Large-Scale Applied Research Project Competition – Genomics and Personalized Health – funded 17 projects with the objective to demonstrate how genomics-based research could contribute to improve the cost-effectiveness of the health-care system.
Each project involves research from the perspective of the social sciences and humanities. Known as GE3LS research (Genomics and its Ethical, Environmental, Economic, Legal and Social aspects), this research is identifying ways to optimize the integration of genomics technology into the health care system.
Co-led by Drs. Christopher McCabe, of the University of Alberta, and François Rousseau, of Université Laval, the new Network brings together GE3LS researchers from all 17 projects to address overarching themes:
- research ethics review;
- health economics and health technology assessment;
- knowledge transfer and implementation in health systems for ‘omics technologies; and,
- intellectual property and commercialization.
GE3LS Network in Genomics and Personalized Health
The 2012 Genome Canada Large-Scale Applied Research Project Competition – Genomics and Personalized Health (GAPH) funded 17 projects. Each project integrates technology assessment and social science and humanities research under the banner of the signature Genome Canada GE3LS initiative.
In 2016, Genome Canada announced funding for a network to bring together GE3LS researchers from all 17 projects. The Network will enable the projects to share best practices; improve and prime future collaborative research; accelerate the progress to market of GAPH technologies; and maximize the impact of investment in the GAPH projects.
The Network will address four priority GE3LS themes: research ethics review; health economics and health technology assessment; knowledge transfer and implementation in health systems for ‘omics technologies; and intellectual property and commercialization.
This $2 million initiative is designed to accelerate the translation of research results into practical applications in healthcare for the benefit of Canadians. The Government of Canada, through Genome Canada, is investing $1 million in the Network, with the balance of funding to be secured from co-funders.
Objectives for each Network theme were outlined by GE3LS and science representatives from each of the 17 projects at a workshop in April 2015. A Network Management Team (Network co-leads and theme leads) will monitor progress on each objective.
By identifying and directing research to overarching issues that emerge from the GE3LS components of the 17 projects, the Network will accelerate their common goal of transforming research results into practical applications adopted by health systems for the benefit of patients.